Compare Becton Dickinson and Co (BDX) vs Otis Worldwide Corp (OTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Otis Worldwide Corp — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Otis Worldwide Corp trades at $73.45 (market cap $27.74B). The key difference: Becton Dickinson and Co is the larger of the two by market cap, and Otis Worldwide Corp pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| BDX | OTIS | |
|---|---|---|
Market Cap | $48.93B | $27.74B |
Sector | Health | Industrials |
52-Week High | $185.39 | $93.62 |
52-Week Low | $138.62 | $69.34 |
Enterprise Value | $65.03B | $35.77B |
Dividend Yield | 2.34% | 2.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.
The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.
Otis Worldwide (OTIS) trades at $73.99, up 0.22% with a bullish technical signal. The company maintains stable revenue around $14.4B but faces margin pressure despite strong service segment growth. Recent Q2 2026 earnings beat estimates but included guidance cuts, reflecting ongoing challenges in new equipment demand. Analyst consensus remains divided with a $92.50 price target suggesting 25% upside potential.
The investment case hinges on service segment momentum offsetting equipment weakness, but margin compression and elevated debt levels pose risks. With mixed analyst ratings and recent institutional selling, the stock offers value if service margins improve, though execution risks remain elevated in the current economic environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →
